Tag
NYSE: PFE
- Novo Nordisk A/S says FDA extends denecimig review over facility remediation
- Pfizer Inc details 61% EASI‑75 response in tilrekimig trial
- Eli Lilly and Company wins FDA pediatric Olumiant approval for severe alopecia
- Lung cancer innovations showcased at ASCO 2026 as researchers pursue earlier detection
- Oxford Biodynamics surges after Pfizer trial backs blood-based cancer test
- Australian biotech uncovers broader view of tumour genetics with liquid biopsy
- University of Waterloo and Princess Margaret Cancer Centre collaborate on innovative cancer research
- NetraMark demonstrates efficacy of AI to help with clinical trials